Formulation development of a stable influenza recombinant neuraminidase vaccine candidate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Formulation development of a stable influenza recombinant neuraminidase vaccine candidate

Published:2024-03-18 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Li Bing¹,Ustyugova Irina V.²,Szymkowicz Lisa³,Zhu Shaolong³,Ming Marin³,Fung Karen Y. Y.¹,Cortés Guadalupe⁴,James D. Andrew⁵,Hrynyk Michael⁶,Rahman Nausheen¹,Brookes Roger H.¹^ORCID,Ausar Salvador F.¹

Affiliation:

1. Sanofi Global Vaccine Drug Product Development, Toronto, ON, Canada

2. Sanofi Global Immunology, Waltham, MA, USA

3. Sanofi Analytical Sciences, Toronto, ON, Canada

4. Sanofi mRNA & Translational Medicine COVID Franchise, Global Clinical Development, Waltham, MA, USA

5. Sanofi External Research and Development, Toronto, ON, Canada

6. Sanofi Digital Program & Services, Toronto, ON, Canada

Funder

Sanofi

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2304393

Reference41 articles.

1. Lessons learnt from influenza vaccination in immunocompromised children undergoing treatment for cancer

2. Vaccine-Preventable Diseases in Older Adults

3. Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance

4. The Spanish flu

5. Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP